This Request for Tender (RFT) invites qualified contract research organisations (CROs) and antibody production vendors to submit a technical and commercial proposal for high-throughput antibody production and characterisation services in support of an active discovery programme. This is a research-use programme; GMP manufacture is not required, but the issuing organisation requires vendors to demonstrate data integrity practices aligned with 21 CFR Part 11 principles where reasonably achievable, in line with our internal data governance standards.